REQUEST A DEMO
Total
USD $0.00
Search more companies

Lupin Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lupin Ltd. Profile Updated: February 19, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Lupin Limited is a pharmaceutical company that specializes in the development and distribution of generics, complex generics, inhalation products, branded medications, and specialty drugs. Lupin Limited claims to target a worldwide market, offering healthcare solutions in over 100 countries. Its product range includes Rivaroxaban Tablets and various medications for tuberculosis and psoriasis.

Legal Address
Kalpataru Inspire,, 3rd Floor, Off. Western Express Highway
Mumbai; Maharashtra; Postal Code: 400055

Contact Details: Purchase the Lupin Ltd. report to view the information.

Website: http://www.lupin.com

Basic Information
Total Employees:
Purchase the Lupin Ltd. report to view the information.
Outstanding Shares:
Purchase the Lupin Ltd. report to view the information.
Registered Capital:
Purchase the Lupin Ltd. report to view the information.
Financial Auditors:
Purchase the Lupin Ltd. report to view the information.
Incorporation Date:
March 04, 1983
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Chief Executive
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
45.42%
Purchase this report to view the information.
45.36%
Purchase this report to view the information.
35.9%
Purchase this report to view the information.
4.75%
Purchase this report to view the information.
3.24%
Subsidiaries
Avenue Coral Springs, LLC (United States)
100%
Generic Health Pty Ltd. (Australia)
100%
Generic Health SDN. BHD. (Malaysia)
100%
Company Performance
Financial values in the chart are available after Lupin Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
17.93%
Total operating revenue
20.2%
Operating Profit/Loss (EBIT)
69.54%
EBITDA
59.77%
Net Profit/Loss for the Period
54%
Total Equity
0.13%
Operating Profit Margin (ROS)
8.18%
Net Profit Margin
4.53%
Return on Equity (ROE)
1488.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?